1. Ursolic acid protects against cisplatin‑induced ototoxicity by inhibiting oxidative stress and TRPV1‑mediated Ca2+‑signaling
   Yang Di et al, 2020, International Journal of Molecular Medicine CrossRef
2. A comprehensive review of natural products to fight liver fibrosis: Alkaloids, terpenoids, glycosides, coumarins and other compounds
   Xiao Ma et al, 2020, European Journal of Pharmacology CrossRef
3. Targeting delivery of a novel TGF-β type I receptor-mimicking peptide to activated hepatic stellate cells for liver fibrosis therapy via inhibiting the TGF-β1/Smad and p38 MAPK signaling pathways
   Xiaohui Liu et al, 2024, European Journal of Pharmacology CrossRef
4. Ursolic acid: A systematic review of its pharmacology, toxicity and rethink on its pharmacokinetics based on PK-PD model
   Qiang Sun et al, 2020, Fitoterapia CrossRef
5. Molecular mechanisms of endothelial remodeling under doxorubicin treatment
   Ekaterina Podyacheva et al, 2023, Biomedicine & Pharmacotherapy CrossRef
6. Network Pharmacology and Molecular Docking Reveal the Mechanism of Isodon ternifolius (D. Don) Kudo Against Liver Fibrosis
   Jiasheng Deng et al, 2023, Drug Design, Development and Therapy CrossRef
7. Ursolic acid inhibits the activation of smoothened‐independent non‐canonical hedgehog pathway in colorectal cancer by suppressing AKT signaling cascade
   Li Chen et al, 2022, Phytotherapy Research CrossRef
8. The inhibition of Hippo/Yap signaling pathway is required for magnesium isoglycyrrhizinate to ameliorate hepatic stellate cell inflammation and activation
   Li Li et al, 2018, Biomedicine & Pharmacotherapy CrossRef
9. Ursolic acid alleviates Kupffer cells pyroptosis in liver fibrosis by the NOX2/NLRP3 inflammasome signaling pathway
   Yipeng Wan et al, 2022, International Immunopharmacology CrossRef
10. Interaction Mechanisms Between the NOX4/ROS and RhoA/ROCK1 Signaling Pathways as New Anti- fibrosis Targets of Ursolic Acid in Hepatic Stellate Cells
    Chenkai Huang et al, 2019, Frontiers in Pharmacology CrossRef
11. Ursolic acid targets secreted phosphoprotein 1 to regulate Th17 cells against metabolic dysfunction-associated steatotic liver disease
    Yiyuan Zheng et al, 2024, Clinical and Molecular Hepatology CrossRef
12. Nox, Reactive Oxygen Species and Regulation of Vascular Cell Fate
    Denise Burtenshaw et al, 2017, Antioxidants CrossRef
13. Nicotinamide adenine dinucleotide phosphate (NADPH) oxidase (NOX) and liver fibrosis: A review
    Keywan Mortezaee, 2018, Cell Biochemistry and Function CrossRef
14. Hepatoprotective Efficacy and Interventional Mechanism of Qijia Rougan Decoction in Liver Fibrosis
    Xiao-Feng Chen et al, 2022, Frontiers in Pharmacology CrossRef
15. NADPH Oxidase Inhibition in Fibrotic Pathologies
    Karen Bernard et al, 2020, Antioxidants & Redox Signaling CrossRef